NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/11/2021
Back to search
Official data from USPTO
QPROTEOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QPROTEOME
ST13
US500000078629724Class
1, 5, 9
Filing
78629724
Registration
3960628
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
92
Latest update
08/11/2021
Trademark type
Word
Nice classes
1, 5, 9
Filing date
05/13/2005
Registration date
05/17/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/11/2021
Last transaction
08/11/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Hilden, DE
Examiner
ENGEL, MICHAEL
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
QIAGEN GmbH
QIAGEN GmbH
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biotechnical products for industrial and scientific purposessolutions for protein processingprotease inhibitor solutionsdetergent solutionsbuffersreagentsresinsenzymesproteinssolvents for scientificresearchindustrial use; biotechnological productssolutions for protein processingprotease inhibitor solutionsdetergent solutionsbuffersreagentsresinsenzymesproteinssolventsin particular for performing separationisolation and/or purification methods for biopolymersin particular proteinsmacromolecules and biologically active substances for diagnostic purposes; diagnostic preparationsexcept for use in human medicine and veterinary medicine; chemical reagents and solvents except those for purposes in human medicine and veterinary medicine to perform separationisolationand/or purification methods for biopolymersin particular for proteinsmacromolecules and biologically active substances; kits comprising chemical productssolutions for protein processingprotease inhibitors solutionsdetergent solutionsbuffersreagentsresinsenzymesproteinssolventsfor the separation and isolation and/or purification of biopolymersin particular proteinsmacromolecules and biologically active substancesin particular proteins from biological material; cell compartment kits containing extraction buffers and reagents for scientific use; nuclear protein kits containing buffers for isolation and fractionation of nucleic acid binding proteins for scientific use; nuclear subfractionation kits containing buffers for isolation and fractionation of nucleic acid binding proteins for scientific use; total glycoprotein kits containing buffers and reagents for scientific use; mannose glycoprotein kits containing buffers and reagents for scientific use; sialic glycoprotein kits containing buffers and reagents for scientific use; o-glycan glycoprotein kits containing buffers and reagents for scientific use; mitochondria isolation kits containing buffers and reagents for isolation of high-purity mitochondria preparations for scientific use ; plasma membrane protein kits containing buffers and reagents for isolation of plasmamembrane proteins for scientific use; glycoarray kits containing buffers and reagents for scientific use; albumin/IgG depletion kits containing buffers and reagents for scientific use; murine albumin depletion kits containing buffers and reagents for scientific use; bacterial protein prep kits containing buffers and reagents for scientific use; mammalian protein prep kits containing buffers and reagents for scientific use; collection tubes and columns for analysis of glycan makeup and glycoproteins for scientific use
Class 5
Diagnostic preparations and products for use in human medicine and veterinary medicinesolutions for protein processingprotease inhibitor solutionsdetergent solutionsbuffersreagentsresinsenzymesproteinssolvents for the separationisolation and purification of biopolymersin particular of proteinsmacromolecules and biologically active substances; chemicalbiochemical productssolutions for protein processingprotease inhibitor solutionsdetergent solutionsbuffersreagentsresinsenzymesproteinssolventsin particular for performing separationisolation and/or purification methods for biopolymersin particular proteinsmacromolecules and biologically active substances for medical diagnostic purposes; kits comprising products for medical or veterinary medical diagnostic purposessolutions for protein processingprotease inhibitor solutionsdetergent solutionsbuffersreagentsresinsenzymesproteinssolventsin particular for separationisolation and/or purification of biopolymersin particular of proteinsmacromolecules and biological active substancesin particular of proteins from biological material; cell compartment kits containing extraction buffers and reagents for medical use; nuclear protein kits containing buffers for isolation and fractionation of nucleic acid binding proteins for medical use; nuclear subfractionation kits containing buffers for isolation and fractionation of nucleic acid binding proteins for medical use; total glycoprotein kits containing buffers and reagents for medical use; mannose glycoprotein kits containing buffers and reagents for medical use; sialic glycoprotein kits containing buffers and reagents for medical use; o-glycan glycoprotein kits containing buffers and reagents for medical use; mitochondria isolation kits containing buffers and reagents for isolation of high-purity mitochondria preparations for medical use; plasma membrane protein kits containing buffers and reagents for isolation of plasmamembrane proteins for medical use; glycoarray kits containing buffers and reagents for medical use; albumin/IgG depletion kits containing buffers and reagents for medical use; murine albumin depletion kits containing buffers and reagents for medical use; bacterial protein prep kits containing buffers and reagents for medical use; mammalian protein prep kits containing buffers and reagents for medical use; collection tubes and columns for analysis of glycan makeup and glycoproteins for medical use
Class 9
Scientific apparatusinstruments and equipmentbinding supportscrystallization supportscolumnstube extenderscollection tubescartridge filters; optical apparatuses and instruments for use in protein processing; calculating machines; electrical and electronic apparatuses and instruments for research and examination purposes for use in protein processing; laboratory equipmentmeasuring apparatus and instruments for medical or veterinary medical diagnostic purposesfor the separationpurificationand/or isolation of biopolymersmacromolecules and biological active substances and proteins from biological materialsoluble protein separation kits containing buffers and reagents for the preparation of separate protein fractions from cleared cell lysates; related computer software for analysis of glycan makeup and glycoproteins
Publications
History of USPTO decisions and trademark events.
92 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/11/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/11/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/10/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
04/22/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/17/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/10/2017
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/10/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/09/2017
E815
TEAS SECTION 8 & 15 RECEIVED
04/20/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/17/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
05/17/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/01/2011
PUBO
PUBLISHED FOR OPPOSITION
03/01/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/21/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/14/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/14/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/14/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/14/2011
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/03/2010
ALIE
ASSIGNED TO LIE
11/03/2010
PAPER RECEIVED
10/18/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/01/2010
GNRT
NON-FINAL ACTION E-MAILED
10/01/2010
CNRT
NON-FINAL ACTION WRITTEN
10/01/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2010
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
07/28/2010
GPRA
PRIORITY ACTION E-MAILED
07/28/2010
CPRA
PRIORITY ACTION WRITTEN
07/28/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/08/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/07/2010
GNRT
NON-FINAL ACTION E-MAILED
06/07/2010
CNRT
NON-FINAL ACTION WRITTEN
06/07/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/13/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/05/2009
GNRT
NON-FINAL ACTION E-MAILED
12/05/2009
CNRT
NON-FINAL ACTION WRITTEN
12/05/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/04/2009
UNDC
UNDELIVERABLE MAIL - COURTESY COPY MAILED
06/26/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/25/2009
GNRT
NON-FINAL ACTION E-MAILED
06/25/2009
CNRT
NON-FINAL ACTION WRITTEN
06/25/2009
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/01/2009
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/31/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/18/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/18/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/01/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/30/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/30/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/12/2009
GNRT
NON-FINAL ACTION E-MAILED
01/12/2009
CNRT
NON-FINAL ACTION WRITTEN
01/12/2009
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/28/2008
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/21/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/12/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/11/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
10/16/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2008
PAPER RECEIVED
10/09/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/08/2008
GNRT
NON-FINAL ACTION E-MAILED
04/08/2008
CNRT
NON-FINAL ACTION WRITTEN
04/08/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
01/15/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/15/2008
PAPER RECEIVED
01/07/2008
UNDC
UNDELIVERABLE MAIL - COURTESY COPY MAILED
07/02/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/02/2007
GNRT
NON-FINAL ACTION E-MAILED
07/02/2007
CNRT
NON-FINAL ACTION WRITTEN
07/02/2007
DOCK
ASSIGNED TO EXAMINER
06/12/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
04/23/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/23/2007
PAPER RECEIVED
04/20/2007
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/29/2007
ALIE
ASSIGNED TO LIE
03/29/2007
GNSL
LETTER OF SUSPENSION E-MAILED
09/10/2006
CNSL
SUSPENSION LETTER WRITTEN
09/10/2006
ACEC
AMENDMENT FROM APPLICANT ENTERED
06/29/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/19/2006
PAPER RECEIVED
06/19/2006
GNRT
NON-FINAL ACTION E-MAILED
12/19/2005
CNRT
NON-FINAL ACTION WRITTEN
12/19/2005
DOCK
ASSIGNED TO EXAMINER
12/09/2005
NWAP
NEW APPLICATION ENTERED
05/20/2005
Continuous trademark protection
Get notified about every new filing that threatens QPROTEOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.